Sharps Compliance Corp (SMED) Posts Q3 Loss of 6c/Share

Sharps Compliance Corp (NASDAQ: SMED) reported Q3 EPS of ($0.06), $0.05 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $5.6 million versus the consensus estimate of $6.34 million.

Customer billings were flat at $5.3 million compared to the prior year period. Strong growth in the Professional, Home Health Care, Environmental and Pharmaceutical segments was partially offset by lower flu shot sales in the Retail segment due to the timing of advance orders in the prior year period.

For earnings history and earnings-related data on Sharps Compliance Corp (SMED) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• DA Davidson Reiterates Buy Rating on Boost Run (BRUN)
• UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'